BFTIX
Price
$63.84
Change
-$0.34 (-0.53%)
Updated
Jul 8 closing price
Net Assets
707.27M
GFACX
Price
$70.13
Change
-$0.05 (-0.07%)
Updated
Jul 8 closing price
Net Assets
320.87B
Interact to see
Advertisement

BFTIX vs GFACX

Header iconBFTIX vs GFACX Comparison
Open Charts BFTIX vs GFACXBanner chart's image
Baron Fifth Avenue Growth Instl
Price$63.84
Change-$0.34 (-0.53%)
VolumeN/A
Net Assets707.27M
American Funds Growth Fund of Amer C
Price$70.13
Change-$0.05 (-0.07%)
VolumeN/A
Net Assets320.87B
BFTIX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BFTIX vs. GFACX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFTIX is a Buy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 321B vs. BFTIX (707M). BFTIX (0.00) and GFACX (0.00) have matching dividends . BFTIX was incepted earlier than GFACX: BFTIX (16 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than BFTIX (0.76). BFTIX (26.00) and GFACX (25.00) have comparable annual turnover. GFACX has a lower initial minimum investment than BFTIX: GFACX (250) vs BFTIX (1000000). BFTIX annual gain was more profitable for investors over the last year : 20.44 vs. GFACX (7.12). BFTIX return over 5 years is better than : 40.61 vs. GFACX (34.84).
BFTIXGFACXBFTIX / GFACX
Total Expense Ratio0.751.3655%
Annual Report Gross Expense Ratio0.761.3656%
Fund Existence16 years24 years-
Gain YTD8.2489.99183%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets707M321B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year20.447.12287%
Returns for 3 years95.6147.39202%
Returns for 5 years40.6134.84117%
Returns for 10 years233.8466.11354%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZVRA11.550.28
+2.48%
Zevra Therapeutics
OVBC34.170.30
+0.89%
Ohio Valley Banc Corp
EVO4.210.03
+0.72%
Evotec SE
OKTA97.530.13
+0.13%
Okta
GPUS1.37-0.02
-1.44%
Hyperscale Data Inc